5 Best Performing NASDAQ Stocks in 2022

Page 1 of 5

In this article, we discuss 5 best performing NASDAQ stocks in 2022. If you want to see more stocks in this selection, check out 12 Best Performing NASDAQ Stocks in 2022

5. CTI BioPharma Corp. (NASDAQ:CTIC)

Number of Hedge Fund Holders: 23

YTD Share Price Gain as of December 27: 126.10%

CTI BioPharma Corp. (NASDAQ:CTIC) was incorporated in 1991 and is headquartered in Seattle, Washington. It is a biopharmaceutical company focused on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. On November 8, CTI BioPharma Corp. (NASDAQ:CTIC) traded 17.5% higher after the company posted better-than-anticipated Q3 results. In the third quarter, CTI BioPharma Corp. (NASDAQ:CTIC) commercially launched VONJO in the United States, reporting net revenue of $18.2 million, a 48% increase in sales compared to the second quarter of 2022. It is one of the best performing NASDAQ stocks in 2022.

On October 17, SVB Securities analyst Andrew Berens initiated coverage of CTI BioPharma Corp. (NASDAQ:CTIC) with an Outperform rating and a $13 price target.

According to Insider Monkey’s third quarter database, 23 hedge funds were bullish on CTI BioPharma Corp. (NASDAQ:CTIC), compared to 17 funds in the prior quarter. Mark Lampert’s Biotechnology Value Fund / BVF Inc is the largest stakeholder of the company, with 8.81 million shares worth $51.3 million. 

Follow Cti Biopharma Corp (NASDAQ:CTIC)

Page 1 of 5